SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PharmaEssentia announces preclinical data on cancer drug PEC3001

PharmaEssentia says it will announce preclinical data on its cancer drug PEC3001.

Related stories